Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aralez Pharm Inc (ARLZ)

Aralez Pharm Inc (ARLZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aralez Pharm Inc 7100 WEST CREDIT AVENUE SUITE 101 MISSISSAUGA A6 L5N 0E4 CAN

www.aralez.com P: 905-876-1118

Description:

Aralez Pharmaceuticals Inc. is a global specialty pharmaceutical company. They acquire, develop and commercialize products primarily in cardiovascular, pain and other specialty areas.

Key Statistics

Overview:

Market Capitalization, $K 2,284
Shares Outstanding, K 67,190
Annual Sales, $ 105,950 K
Annual Net Income, $ -125,210 K
Last Quarter Sales, $ 38,080 K
Last Quarter Net Income, $ -19,740 K
60-Month Beta 1.20
% of Insider Shareholders 10.30%
% of Institutional Shareholders 14.22%

Growth:

1-Year Return -97.02%
3-Year Return -99.62%
5-Year Return -99.34%
5-Year Revenue Growth 1,880.37%
5-Year Earnings Growth -42.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/09/17
Latest Earnings Date 08/22/18
Earnings Per Share ttm -1.45
EPS Growth vs. Prev Qtr 21.62%
EPS Growth vs. Prev Year 30.95%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 1.750 on 12/31/13
Dividend Payout Ratio 0.00%

ARLZ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -271.44%
Return-on-Assets % -20.46%
Profit Margin % -118.18%
Debt/Equity 18.05
Price/Sales 0.03
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.10
Interest Coverage -3.55

ARLZ Dividends

Date Value
12/31/13 $1.7500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar